Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.19382 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.15864 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.16439 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.09728 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.08606 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.34081 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.186 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.13293 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.10466 | 48 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.13257 | 48 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.14386 | 48 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.11397 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.15018 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.15032 | 49 |